UBS Group’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Buy
30,735
+12,640
+70% +$413K ﹤0.01% 5441
2025
Q4
$544K Sell
18,095
-18,665
-51% -$528K ﹤0.01% 6024
2025
Q3
$964K Sell
36,760
-13,412
-27% -$320K ﹤0.01% 5604
2025
Q2
$1.07M Buy
50,172
+44,839
+841% +$1.01M ﹤0.01% 5404
2025
Q1
$113K Sell
5,333
-284
-5% -$5.83K ﹤0.01% 6959
2024
Q4
$114K Buy
+5,617
New +$116K ﹤0.01% 6788

Other funds holding GRDN

UBS Group's GRDN Position: Q1 2026 in Review

UBS Group increased its Guardian Pharmacy Services (GRDN) stake by 70% in Q1 2026, buying an estimated $413K and bringing the position to 30,735 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #5441.

UBS Group first reported a position in GRDN in Q4 2024 and has held it in 6 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • UBS Group held 30,735 shares of Guardian Pharmacy Services worth $1.16M as of Q1 2026.
  • UBS Group bought 12,640 Guardian Pharmacy Services shares in Q1 2026, an estimated $413K.
  • Guardian Pharmacy Services made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5441 holding.
  • UBS Group first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 6 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.